These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 23824744)

  • 21. Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
    Soga T; Sugimoto M; Honma M; Mori M; Igarashi K; Kashikura K; Ikeda S; Hirayama A; Yamamoto T; Yoshida H; Otsuka M; Tsuji S; Yatomi Y; Sakuragawa T; Watanabe H; Nihei K; Saito T; Kawata S; Suzuki H; Tomita M; Suematsu M
    J Hepatol; 2011 Oct; 55(4):896-905. PubMed ID: 21334394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
    Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
    J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry.
    Yin P; Wan D; Zhao C; Chen J; Zhao X; Wang W; Lu X; Yang S; Gu J; Xu G
    Mol Biosyst; 2009 Aug; 5(8):868-76. PubMed ID: 19603122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
    Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
    Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
    Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
    Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
    Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
    J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C.
    Saito T; Sugimoto M; Okumoto K; Haga H; Katsumi T; Mizuno K; Nishina T; Sato S; Igarashi K; Maki H; Tomita M; Ueno Y; Soga T
    World J Gastroenterol; 2016 Jul; 22(27):6224-34. PubMed ID: 27468212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of PinX1 in human hepatocellular carcinoma.
    Oh BK; Chae KJ; Park C; Park YN
    Oncol Rep; 2004 Oct; 12(4):861-6. PubMed ID: 15375513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
    Wang W; Zhao LJ; Wang Y; Tao QY; Feitelson MA; Zhao P; Ren H; Qi ZT
    Cancer Biomark; 2011-2012; 11(1):29-39. PubMed ID: 22820138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
    Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
    Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry.
    Zhou L; Ding L; Yin P; Lu X; Wang X; Niu J; Gao P; Xu G
    J Proteome Res; 2012 Nov; 11(11):5433-42. PubMed ID: 22946841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L; Shen AG; Wang GL; Lu P; Li XY
    Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
    Park BC; Huh MH; Seo JH
    J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma.
    Hou G; Xu W; Ding D; Tian T; Liu G; Yang Y; Liu H; Zhou W
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2321-2330. PubMed ID: 36208127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.
    Xia H; Chen J; Sekar K; Shi M; Xie T; Hui KM
    Metabolomics; 2019 Nov; 15(12):156. PubMed ID: 31773292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma.
    Czeczot H; Scibior D; Skrzycki M; Podsiad M
    Acta Biochim Pol; 2006; 53(1):237-42. PubMed ID: 16404476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma].
    Xie YM; Li X; Yan LN; Wei B; Wang CH; Tang CW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):710-6. PubMed ID: 26619541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
    Wang L; Huang J; Jiang M; Sun L
    J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.